Standard BioTools Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:FLB Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
27 Aug 24	Buy€489,724	Casdin Capital, LLC	Company	250,000	€1.96
26 Aug 24	Buy€1,384,655	Casdin Capital, LLC	Company	750,000	€1.93
21 Aug 24	Buy€2,112,925	Casdin Capital, LLC	Company	1,250,000	€1.71
14 Aug 24	Buy€1,735,371	Casdin Capital, LLC	Company	1,200,000	€1.45
14 Aug 24	Buy€1,735,371	Casdin Capital, LLC	Company	1,200,000	€1.45
13 Aug 24	Buy€2,336,697	Casdin Capital, LLC	Company	1,575,408	€1.50
08 Aug 24	Buy€1,575,453	Casdin Capital, LLC	Company	1,069,562	€1.50
05 Aug 24	Buy€1,776,027	Casdin Capital, LLC	Company	1,200,000	€1.49
23 May 24	Buy€240,214	Casdin Capital, LLC	Company	100,000	€2.40
22 May 24	Buy€1,422,923	Casdin Capital, LLC	Company	600,000	€2.39
17 May 24	Buy€3,178,409	Casdin Capital, LLC	Company	1,352,072	€2.36
05 Mar 24	Buy€594,605	Casdin Capital, LLC	Company	251,403	€2.41

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of FLB?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	16,515	0.00444%
Individual Insiders	5,180,378	1.39%
General Public	54,935,309	14.8%
Hedge Funds	58,651,170	15.8%
VC/PE Firms	71,254,677	19.1%
Institutions	182,220,749	49%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.4%.

Top Shareholders

Top 25 shareholders own 79.86% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.1%	Casdin Capital, LLC	71,254,677	€88.5m	0%	6.34%
15.8%	Viking Global Investors LP	58,651,170	€72.9m	0%	0.25%
10.6%	Nippon Life India Asset Management Limited	39,296,310	€48.8m	0%	0.13%
6.68%	BlackRock, Inc.	24,857,850	€30.9m	10.7%	no data
4.61%	The Vanguard Group, Inc.	17,156,146	€21.3m	-0.79%	no data
4.22%	Morgan Stanley Investment Management Inc.	15,715,326	€19.5m	14.4%	0.02%
1.9%	Millennium Management LLC	7,081,711	€8.8m	1.4%	0.01%
1.87%	Geode Capital Management, LLC	6,975,221	€8.7m	0.37%	no data
1.78%	Nikko Asset Management Co., Ltd.	6,618,394	€8.2m	-65.4%	no data
1.76%	Tikvah Management LLC	6,551,058	€8.1m	0%	2.52%
1.69%	State Street Global Advisors, Inc.	6,290,000	€7.8m	14.5%	no data
1.48%	Hollow Brook Wealth Management LLC	5,503,381	€6.8m	-0.53%	2.25%
1.23%	Neuberger Berman Investment Advisers LLC	4,580,053	€5.7m	-3.17%	no data
0.89%	ARK Investment Management LLC	3,323,689	€4.1m	-62.9%	0.03%
0.87%	Barclays PLC Private Banking & Investment Banking Investment	3,230,851	€4.0m	0.95%	no data
0.84%	Mirabella Financial Services LLP	3,130,190	€3.9m	0%	no data
0.77%	Northern Trust Global Investments	2,875,160	€3.6m	9.25%	no data
0.73%	Eli Casdin	2,703,532	€3.4m	0%	no data
0.63%	Charles Schwab Investment Management, Inc.	2,332,649	€2.9m	-4.6%	no data
0.57%	Kent Lake PR LLC	2,131,345	€2.6m	0%	1.04%
0.51%	Pivotal BioVenture Partners LLC	1,883,179	€2.3m	0%	0.97%
0.43%	Slate Path Capital LP	1,615,000	€2.0m	0%	0.04%
0.39%	Royce & Associates, LP	1,455,503	€1.8m	137%	0.02%
0.3%	Morgan Stanley, Investment Banking and Brokerage Investments	1,118,202	€1.4m	-24.9%	no data
0.26%	UBS Asset Management AG	957,356	€1.2m	70.9%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/22 04:15
End of Day Share Price	2025/02/21 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Standard BioTools Inc. is covered by 13 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Sung Ji Nam	BTIG
Bryan Brokmeier	Cantor Fitzgerald & Co.
Shawn Bevec	Deutsche Bank